SHARI HERRON: Open Payments
NPI 1871996249 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,018 in 55 payments from 11 companies in 2025. Trend: 2023 $1,566 · 2024 $1,561 · 2025 $1,018
Food & beverage: $1,018
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $222 |
| ABBVIE INC. | 10 | $178 |
| Novo Nordisk Inc | 7 | $134 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $120 |
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| Phathom Pharmaceuticals, Inc. | 4 | $68 |
| Amgen Inc. | 4 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $42 |
| Exact Sciences Corporation | 2 | $31 |
Products named: NURTEC ODT, Kerendia, UBRELVY, VOQUEZNA, VRAYLAR, Ozempic, PREVNAR 20, Wegovy.
Industry payments across OK — which companies pay providers there.
